Segisafe
Segisafe is a pharmaceutical product marketed by Seginus Cure Pharma. It is supplied for professional use and distributed through authorized healthcare channels.
Advanced Neuro-Protection for Brain Recovery & Cognitive Strength
It is a next-generation neurotrophic therapy formulated with Cerebroprotein Hydrolysate, a biologically active peptide complex that mimics natural nerve growth factors. It is designed to protect neurons, enhance brain repair, and support functional recovery in neurological and cognitive disorders.
It is an ideal therapeutic choice for stroke rehabilitation, dementia, traumatic brain injury, and neurodegenerative conditions, helping patients regain cognitive and functional independence.
Advantages
Neurotrophic Peptide Technology – Mimics natural brain growth factors
Accelerates Neuronal Repair & Regeneration
Improves Synaptic Plasticity & Cognitive Functions
Dual Formulation Advantage – Injection for acute phase, tablet for long-term maintenance
Proven Neuroprotective Action against ischemic and degenerative damage
Supports Functional Recovery in Stroke & Brain Injury
Therapeutic Uses
Ischemic and hemorrhagic stroke rehabilitation
Alzheimer’s disease & other dementias
Traumatic brain injury (TBI)
Vascular dementia
Parkinson’s disease (adjunct therapy)
Cognitive impairment due to aging
Post-hypoxic brain damage
Enhances memory, attention, and learning ability
Promotes faster neurological recovery
Reduces neuronal apoptosis and oxidative stress
Improves daily functioning and quality of life
Supports long-term brain health and neuroplasticity
SEGISAFE Injection 60 mg – For hospital and acute neurological care
SEGISAFE Tablet 90 mg – For continuation and maintenance therapy
Safety Advice
Use only under medical supervision
Injection should be administered by a qualified healthcare professional
Dose and duration should be strictly followed as prescribed
Inform your doctor if you have a history of epilepsy, severe renal disease, or allergies
Not recommended during pregnancy and lactation unless clearly advised by a physician
Disclaimer
SEGISAFE is a prescription medicine. The information provided here is for educational and informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting or modifying any therapy.
Frequently Asked Questions (FAQs)
It is used to support brain recovery in conditions like stroke, dementia, traumatic brain injury, and cognitive decline.
It contains low-molecular-weight neuropeptides that cross the blood–brain barrier and act like natural neurotrophic factors, enhancing neuronal survival and repair.
Yes, tablets are commonly prescribed for long-term neuroprotection and cognitive support under medical supervision.
Yes, it is widely used in elderly patients, especially those with dementia or post-stroke cognitive impairment, as advised by a physician.
Clinical improvement may be noticed within a few weeks, depending on the condition, severity, and duration of treatment.